biOasis Technologies Ord Shs BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs > The vote

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Jan 12, 2023 12:13am

67 Views

Post# 35217495

RE:RE:RE:RE:RE:RE:RE:RE:RE:The vote

Nope, no such person in my family like that, Craig. Like I said earlier, you like to listen to yourself yap so much that you can't hear what anybody else is saying.

Bad trait.

jd

<< Previous

Bullboard Posts

Next >>

Futures Flat Amid Key Data in Canada and US